{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT06777628",
      "orgStudyIdInfo": {
        "id": "Immunecheck"
      },
      "organization": {
        "fullName": "IRCCS Azienda Ospedaliero-Universitaria di Bologna",
        "class": "OTHER"
      },
      "briefTitle": "Immunophenotype of PBMC to Early Predict Response to Immunotherapy in Hepatocellular Carcinoma",
      "officialTitle": "Immunophenotype of Peripheral Blood Mononuclear Cells to Early Predict Response to Immunotherapy in Hepatocellular Carcinoma",
      "acronym": "Immunecheck"
    },
    "statusModule": {
      "statusVerifiedDate": "2024-09",
      "overallStatus": "RECRUITING",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2024-09-15",
        "type": "ACTUAL"
      },
      "primaryCompletionDateStruct": {
        "date": "2026-10-15",
        "type": "ESTIMATED"
      },
      "completionDateStruct": {
        "date": "2028-10-15",
        "type": "ESTIMATED"
      },
      "studyFirstSubmitDate": "2024-11-28",
      "studyFirstSubmitQcDate": "2025-01-14",
      "studyFirstPostDateStruct": {
        "date": "2025-01-16",
        "type": "ACTUAL"
      },
      "lastUpdateSubmitDate": "2025-01-14",
      "lastUpdatePostDateStruct": {
        "date": "2025-01-16",
        "type": "ACTUAL"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "type": "SPONSOR"
      },
      "leadSponsor": {
        "name": "IRCCS Azienda Ospedaliero-Universitaria di Bologna",
        "class": "OTHER"
      }
    },
    "oversightModule": {
      "oversightHasDmc": true,
      "isFdaRegulatedDrug": false,
      "isFdaRegulatedDevice": false
    },
    "descriptionModule": {
      "briefSummary": "The study is aimed to test the performance of a simple, easy, reproducible cytofluorimetric assay to complement imaging studies for:\n\n* predicting response to immune-therapeutic regimens in HCC in the early phase of treatment,\n* to rule out pseudo-progression,\n* to early predict the escape from effectiveness of treatment.",
      "detailedDescription": "* To assess the accuracy of biomarkers from an immunophenotypic test (CD8+, PD1+, PD-L1+, CTLA4+, LAG3+, CD8+PD1+, CD8+PDL1+ peripheral lymphocyte populations and circulating granulocytes) in predicting the response to immuno-therapy in patients affected by hepatocellular carcinoma (HCC).\n* To compare the transcriptomic signatures of peripheral blood mononuclear cells (PBMC) of responders and non-responders (assessed at the first imaging study).\n\nRNAseq data will be validated by RT-PCR in independent prospective cohorts."
    },
    "conditionsModule": {
      "conditions": [
        "Liver Cancer, Adult"
      ],
      "keywords": [
        "immunophenotype",
        "HCC patients",
        "immunotherapy"
      ]
    },
    "designModule": {
      "studyType": "OBSERVATIONAL",
      "patientRegistry": true,
      "targetDuration": "3 Years",
      "designInfo": {
        "observationalModel": "CASE_ONLY",
        "timePerspective": "PROSPECTIVE"
      },
      "bioSpec": {
        "retention": "SAMPLES_WITHOUT_DNA",
        "description": "peripheral blood mononuclear cells separated by Ficoll gradient"
      },
      "enrollmentInfo": {
        "count": 100,
        "type": "ESTIMATED"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "HCC patients",
          "description": "Patients with advanced HCC undergoing immunotherapy",
          "interventionNames": [
            "Drug: Immunochemotherapy combined with antiangiogenic"
          ]
        }
      ],
      "interventions": [
        {
          "type": "DRUG",
          "name": "Immunochemotherapy combined with antiangiogenic",
          "description": "Immunochemotherapy combined with antiangiogenic",
          "armGroupLabels": [
            "HCC patients"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "To find predictive biomarkers of response to immunotherapy in HCC",
          "description": "Sensitivity and specificity of CD8+, PD1+, PD-L1+, CTLA4+, LAG3+, TIGIT+, CD8+PD1+, CD8+PDL1+ peripheral lymphocytes and granulocytes for tumor response prediction according to RECIST 1.1 criteria",
          "timeFrame": "at 3 month"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "To compare the transcriptomic signatures of PBMC of responders and non-responders",
          "description": "Tumor response according to RECIST 1.1 criteria",
          "timeFrame": "At 3 months"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n* age â‰¥ 18 years\n* diagnosis of HCC\n* execution of laboratory tests and subsequent treatments and follow-up at our center.\n* obtained written informed consent to the study participation\n\nExclusion Criteria:\n\n* immune-related concomitant diseases\n* HIV infection",
      "healthyVolunteers": false,
      "sex": "ALL",
      "minimumAge": "18 Years",
      "stdAges": [
        "ADULT",
        "OLDER_ADULT"
      ],
      "studyPopulation": "patients with advanced hepatocellular carcinoma",
      "samplingMethod": "NON_PROBABILITY_SAMPLE"
    },
    "contactsLocationsModule": {
      "centralContacts": [
        {
          "name": "Laura Gramantieri, MD",
          "role": "CONTACT",
          "phone": "0512142579",
          "email": "laura.gramantieri@aosp.bo.it"
        }
      ],
      "overallOfficials": [
        {
          "name": "Laura Gramantieri",
          "affiliation": "IRCCS Azienda Ospedaliero-Universitaria di Bologna",
          "role": "PRINCIPAL_INVESTIGATOR"
        }
      ],
      "locations": [
        {
          "facility": "IRCCS-Azienda Ospedaliero-Universitaria di Bologna",
          "status": "RECRUITING",
          "city": "Bologna",
          "state": "Laura Gramantieri",
          "zip": "40138",
          "country": "Italy",
          "contacts": [
            {
              "name": "Laura Gramantieri, MD",
              "role": "CONTACT",
              "phone": "+390512142214",
              "email": "laura.gramantieri@aosp.bo.it"
            }
          ],
          "geoPoint": {
            "lat": 44.49381,
            "lon": 11.33875
          }
        }
      ]
    },
    "ipdSharingStatementModule": {
      "ipdSharing": "UNDECIDED"
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-17"
    },
    "conditionBrowseModule": {
      "meshes": [
        {
          "id": "D006528",
          "term": "Carcinoma, Hepatocellular"
        }
      ],
      "ancestors": [
        {
          "id": "D000230",
          "term": "Adenocarcinoma"
        },
        {
          "id": "D002277",
          "term": "Carcinoma"
        },
        {
          "id": "D009375",
          "term": "Neoplasms, Glandular and Epithelial"
        },
        {
          "id": "D009370",
          "term": "Neoplasms by Histologic Type"
        },
        {
          "id": "D009369",
          "term": "Neoplasms"
        },
        {
          "id": "D008113",
          "term": "Liver Neoplasms"
        },
        {
          "id": "D004067",
          "term": "Digestive System Neoplasms"
        },
        {
          "id": "D009371",
          "term": "Neoplasms by Site"
        },
        {
          "id": "D004066",
          "term": "Digestive System Diseases"
        },
        {
          "id": "D008107",
          "term": "Liver Diseases"
        }
      ]
    },
    "interventionBrowseModule": {
      "meshes": [
        {
          "id": "D020533",
          "term": "Angiogenesis Inhibitors"
        }
      ],
      "ancestors": [
        {
          "id": "D043924",
          "term": "Angiogenesis Modulating Agents"
        },
        {
          "id": "D006133",
          "term": "Growth Substances"
        },
        {
          "id": "D045505",
          "term": "Physiological Effects of Drugs"
        },
        {
          "id": "D020228",
          "term": "Pharmacologic Actions"
        },
        {
          "id": "D020164",
          "term": "Chemical Actions and Uses"
        },
        {
          "id": "D006131",
          "term": "Growth Inhibitors"
        },
        {
          "id": "D000970",
          "term": "Antineoplastic Agents"
        },
        {
          "id": "D045506",
          "term": "Therapeutic Uses"
        }
      ]
    }
  },
  "hasResults": false
}